Amanote Research
Register
Sign In
The Impacts of Zanubrutinib on Immune Cells in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Hematological Oncology
- United Kingdom
doi 10.1002/hon.47_2631
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Cancer Research
Oncology
Hematology
Date
June 1, 2019
Authors
Y. Zou
H. Zhu
X. Li
Y. Xia
K. Miao
S. Zhao
Y. Wu
L. Wang
W. Xu
J. Li
Publisher
Wiley
Related search
Composite Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Cytometry Part B - Clinical Cytometry
Forensic Medicine
Pathology
Histology
Cell Biology
A Phase I/Ii Study of Rituximab and Etanercept in Patients With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Coevolution of Leukemia and Host Immune Cells in Chronic Lymphocytic Leukemia
Cold Spring Harbor perspectives in medicine
Biochemistry
Medicine
Genetics
Molecular Biology
Transcend CLL 004: Minimal Residual Disease After Lisocabtagene Maraleucel in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Outcomes With Bruton Tyrosine Kinase Inhibition in Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma After Progression on Venetoclax
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
The Prognostic Significance of Cytopenia in Chronic Lymphocytic Leukaemia/Small Lymphocytic Lymphoma
British Journal of Haematology
Hematology
Small Lymphocytic Lymphoma
Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer Research
Oncology
Genetics
Hematology
Chronic Lymphocytic Leukemia
Current Opinion in Hematology
Hematology
An Improved Benefit-Risk Profile of Duvelisib in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Who Received 2 or More Prior Therapies
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
